tiprankstipranks
Crinetics Pharmaceuticals (CRNX)
NASDAQ:CRNX
US Market

Crinetics Pharmaceuticals (CRNX) Ownership - Who Owns Crinetics Pharmaceuticals?

Compare
500 Followers

Crinetics Pharmaceuticals (CRNX) Ownership Overview

2.04%38.93%38.69%16.07%4.28%
38.69% Other Institutional Investors
16.07% ETFs
4.28% Public Companies and
Individual Investors
The ownership structure of Crinetics Pharmaceuticals (CRNX) stock is a mix of institutional, retail, and individual investors. Approximately 93.68% of the company’s stock is owned by Institutional Investors, 2.04% is owned by Insiders, and 4.28% is owned by Public Companies and Individual Investors.
The ownership structure of Crinetics Pharmaceuticals (CRNX) stock is a mix of institutional, retail, and individual investors. Approximately 77.62% of the company’s stock is owned by Institutional Investors, 2.04% is owned by Insiders, and 16.07% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 25, 2024
Dana Pizzuti
Chief Med And Dev Officer
xxxxxxxxxxxxx
$434435

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2024
xxxxxxxxxxxxx
$1280499
Dec 31, 2024
xxxxxxxxxxxxx
$2556500
Dec 31, 2024
xxxxxxxxxxxxx
$6273651
Dec 31, 2024
xxxxxxxxxxxxx
$9434763

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
8,512,595Institution9.15%293,429,150
7,748,027Institution8.33%267,074,491
6,141,014Institution6.60%211,680,753
4,095,815Institution4.40%141,182,743
4,075,098Institution4.38%140,468,628
2,284,367Institution2.46%78,742,130
2,143,992Institution2.30%73,903,404
1,754,946Institution1.89%60,492,989
1,464,650Institution1.57%50,486,486
1,252,553Institution1.35%43,175,502

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
7,748,027Institution8.33%267,074,491
2,284,367Institution2.46%78,742,130
2,143,992Institution2.30%73,903,404
1,754,946Institution1.89%60,492,989
1,464,650Institution1.57%50,486,486
1,252,553Institution1.35%43,175,502
1,169,994Institution1.26%40,329,693
1,104,599Institution1.19%38,075,528
1,006,709Institution1.08%34,701,259
978,722Institution1.05%33,736,547

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,822,183Institution3.03%100,977,708
2,358,586Institution2.53%81,300,459
2,242,579Institution2.41%114,663,064
1,421,646Institution1.53%50,866,494
1,271,005Institution1.37%51,221,502
848,706Institution0.91%29,738,658
770,363Institution0.83%26,554,413
529,120Institution0.57%18,238,766
434,270Institution0.47%15,216,821
402,017Institution0.43%14,384,168

FAQ

Who Owns Crinetics Pharmaceuticals (CRNX)?
According to the latest TipRanks data, approximately 38.69% of the company's stock is held by institutional investors, 2.04% is held by insiders, and 4.28% is held by retail investors.
    What percentage of Crinetics Pharmaceuticals (CRNX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 38.69% of Crinetics Pharmaceuticals (CRNX) stock is held by institutional investors.
      What percentage of Crinetics Pharmaceuticals (CRNX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 4.28% of Crinetics Pharmaceuticals (CRNX) stock is held by retail investors.
        Who owns the most shares of Crinetics Pharmaceuticals (CRNX)?
        Vanguard owns the most shares of Crinetics Pharmaceuticals (CRNX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis